Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Company Description (as filed with the SEC)
We are a biopharmaceutical company engaged in developing novel allogeneic, "off-the-shelf" cellular therapeutic vaccines to combat a wide range of cancers and infectious diseases. Our proprietary ImPACT(TM) Immune Pan Antigen Cytotoxic Therapy has been designed to deliver live, genetically-modified, irradiated human cells which secrete a broad spectrum of disease-associated antigens together with a potent immune response stimulator called "gp96." The secreted antigen-gp96 complexes educate and activate a patient's immune system to recognize and kill diseased cells. In cancer patients our ImPACT(TM) therapy generates anti-cancer immune responses by mobilizing and activating cytotoxic "killer" T cells that target multiple cancer antigens, thus harnessing a patient's own immune system to fight cancer. ... More ...
Where does HTBX fit in the risk graph?
|Annual EPS Est:||$-1.83|
|Quarterly EPS Est:||-0.49|